- 专利标题: Single-stranded oligonucleotide
-
申请号: US16073114申请日: 2017-01-26
-
公开(公告)号: US11530409B2公开(公告)日: 2022-12-20
- 发明人: Yusuke Iriyama , Hiroyuki Nakajima , Tatsuro Kanaki
- 申请人: NISSAN CHEMICAL CORPORATION
- 申请人地址: JP Tokyo
- 专利权人: NISSAN CHEMICAL CORPORATION
- 当前专利权人: NISSAN CHEMICAL CORPORATION
- 当前专利权人地址: JP Tokyo
- 代理机构: Leydig, Voit & Mayer, Ltd.
- 优先权: JPJP2016-012804 20160126,JPJP2016-158833 20160812
- 国际申请: PCT/JP2017/002831 WO 20170126
- 国际公布: WO2017/131124 WO 20170803
- 主分类号: C07H21/04
- IPC分类号: C07H21/04 ; C12N15/113 ; A61K48/00 ; A61K31/7088 ; C12P19/34
摘要:
Provided is a single-stranded oligonucleotide that is capable of controlling a target gene with high efficiency and can be easily produced. The single-stranded oligonucleotide is represented by the formula X-L-Y wherein X and Y hybridize by a first nucleotide sequence portion and a second nucleotide sequence portion. X is composed of 7 to 100 nucleotides, contains at least one modified nucleotide, and has a first nucleotide sequence that is capable of hybridizing with a second oligonucleotide and contains at least four contiguous nucleotides recognized by RNase H. Y is composed of 4 to 100 nucleotides, and has a second nucleotide sequence that is capable of hybridizing with a second oligonucleotide and contains at least one ribonucleotide. At least one of nucleotide sequence X and nucleotide sequence Y has an antisense sequence capable of hybridizing with a target RNA. L is a group derived from a third oligonucleotide that is degraded under physiological conditions.
公开/授权文献
- US20190119683A1 SINGLE-STRANDED OLIGONUCLEOTIDE 公开/授权日:2019-04-25
信息查询